Cited by 538Antifungal resistance and susceptibilityFungal Infections and StudiesAntibiotics Pharmacokinetics and Efficacy

The DOI matches its Crossref record; 119 of the 119 references it cites were found in a registry or an index.

Liposomal Amphotericin B (AmBisome®): A Review of the Pharmacokinetics, Pharmacodynamics, Clinical Experience and Future Directions

Open access

Stone, Neil R. H., Bicanic, Tihana, Salim, Rahuman, Hope, William·2016·Drugs

DOI 10.1007/s40265-016-0538-7PMC PMC4856207

Open this paper in CoChat — free account

Abstract

Liposomal amphotericin B (AmBisome(®); LAmB) is a unique lipid formulation of amphotericin B. LAmB is a standard of care for a wide range of medically important opportunistic fungal pathogens. LAmB has a significantly improved toxicity profile compared with conventional amphotericin B deoxycholate (DAmB). Despite nearly 20 years of clinical use, the pharmacokinetics and pharmacodynamics of this agent, which differ considerably from DAmB, remain relatively poorly understood and underutilized in the clinical setting. The molecular pharmacology, preclinical and clinical pharmacokinetics, and clinical experience with LAmB for the most commonly encountered fungal pathogens are reviewed. In vitro, experimental animal models and human clinical trial data are summarized, and novel routes of administration and dosing schedules are discussed. LAmB is a formulation that results in reduced toxicity as compared with DAmB while retaining the antifungal effect of the active agent. Its long terminal half-life and retention in tissues suggest that single or intermittent dosing regimens are feasible, and these should be actively investigated in both preclinical models and in clinical trials. Significant gaps remain in knowledge of pharmacokinetics and pharmacodynamics in special populations such as neonates and children, pregnant women and obese patients.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1007/s40265-016-0538-7

Cites

119 of 119 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Diffusion of univalent ions across the lamellae of swollen phospholipids
Bangham, A. D., Standish, M. M., & Watkins, J. C. (1965) · Journal of Molecular Biology · doi:10.1016/s0022-2836(65)80093-6 · Cited by 4,664
Bone marrow transplant
Szer, J. (1999) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1999.tb127745.x · Cited by 3,373
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
Walsh, T. J., Anaissie, E. J., Denning, D. W., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Segal, B. H., Steinbach, W. J., Stevens, D. A., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/525258 · Cited by 2,705
Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
Perfect, J. R., Dismukes, W. E., Dromer, F., Goldman, D. L., Graybill, J. R., Hamill, R. J., Harrison, T. S., Larsen, R. A., Lortholary, O., Nguyen, M.-H., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/649858 · Cited by 2,660
Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia
Walsh, T. J., Finberg, R. W., Arndt, C., Hiemenz, J., Schwartz, C., Bodensteiner, D., Pappas, P., Seibel, N., Greenberg, R. N., Dummer, S., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401004 · Cited by 1,205
Phase transitions in phospholipid vesicles Fluorescence polarization and permeability measurements concerning the effect of temperature and cholesterol
Papahadjopoulos, D., Jacobson, K., Nir, S., & Isac, I. (1973) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(73)90314-3 · Cited by 998
Voriconazole Compared with Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Neutropenia and Persistent Fever
Walsh, T. J., Pappas, P., Winston, D. J., Lazarus, H. M., Petersen, F., Raffalli, J., Yanovich, S., Stiff, P., Greenberg, R., Donowitz, G., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejm200201243460403 · Cited by 979
Caspofungin versus Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Persistent Fever and Neutropenia
Walsh, T. J., Teppler, H., Donowitz, G. R., Maertens, J. A., Baden, L. R., Dmoszyńska, A., Cornely, O. A., Bourque, M. R., Lupinacci, R. J., Sable, C. A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040446 · Cited by 907
Amphotericin B formulations: a comparative review of efficacy and toxicity
Hamill, R. J. (2013) · Drugs · doi:10.1007/s40265-013-0069-4 · Cited by 807
Liposomal Amphotericin B as Initial Therapy for Invasive Mold Infection: A Randomized Trial Comparing a High-Loading Dose Regimen with Standard Dosing (AmBiLoad Trial)
Cornely, O. A., Maertens, J. A., Bresnik, M., Ebrahimi, R., Ullmann, A. J., Bouza, E., Heußel, C. P., Lortholary, O., Rieger, C. T., Boehme, A., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/514341 · Cited by 744

Show all 119 references

Research works printed but not linked: 1

Joint Formulary Committee. British National Formulary. 70th ed. London: BMJ Group and Pharmaceutical Press;2015.

Sorted by citations

Items 401–500 of 538

Fungal infections: advances in diagnosis and treatment
Vijayaraman, R. S., & Pushpanathan, P. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821734-4.00011-3 · Cited by 2
Predicting absorption of amphotericin B encapsulated in a new delivery system by an in vitro Caco-2 cell model
Tadini, M. C., Ballestero, G., Perovani, Í. S., de Albuquerque, N. C. P., Forte, A. L. S. A., Marquele‐Oliveira, F., & de Oliveira, A. R. M. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103345 · Cited by 2
COVID-related mucormycosis mimicking dental infection
Alramadhan, S. A., Sam, S., Young, S., Cohen, D. M., Islam, N., & Bhattacharyya, I. (2023) · Oral and Maxillofacial Surgery Cases · doi:10.1016/j.omsc.2023.100310 · Cited by 2
Successful rapid liposomal amphotericin B desensitization in pediatric case series
Geniş, C., Emeksiz, Z. Ş., Yaytokgil, Ş. B., Giniş, T., İslamoğlu, C., & Mısırlıoğlu, E. D. (2024) · Allergy and Asthma Proceedings · doi:10.2500/aap.2024.45.240008 · Cited by 2
Application of nanotechnology to improve the antileishmanial efficacy of amphotericin B
do Nascimento, T., de Souza, V. T., Ramos, I. D. C., de Almeida, B. C., Santos‐Oliveira, R., & Ricci‐Júnior, E. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105948 · Cited by 2
Comparison of Adverse Event Profiles of Amphotericin B Formulations Using Real-World Data
Nokura, Y., Maezawa, M., Miyasaka, K., Hirofuji, S., Nakao, S., Yamashita, M., Ichihara, N., Sugishita, K., Yamazaki, T., Tamaki, H., et al. (2024) · Cureus · doi:10.7759/cureus.71588 · Cited by 2
Amphotericin B Resistant Aspergillus spp.: Report of Two Cases
Kaya, A., Kaya, S. Y., Balkan, İ. İ., Alkan, S., Kurt, A. F., Elverdi, T., Ürkmez, S., Öngören, Ş., & Aygün, G. (2024) · Infectious Diseases and Clinical Microbiology · doi:10.36519/idcm.2024.371 · Cited by 2
Synthesis and evaluation of the antifungal and antibiofilm potential of aminochalcones
Garcia, M. A. R., Sardi, J. D. C. O., dos Santos, M. B., Lazarini, J. G., Rosalen, P. L., & Regasini, L. O. (2025) · Archives of Microbiology · doi:10.1007/s00203-025-04244-z · Cited by 2
Exploring bioactive molecules released during inter- and intraspecific competition: A paradigm for novel antiparasitic drug discovery and design for human use
Ruenchit, P. (2025) · Current Research in Parasitology and Vector-Borne Diseases · doi:10.1016/j.crpvbd.2025.100256 · Cited by 3
Integrating Modern Modalities for the Advancements and Enhanced Effectivity in Veterinary Medicine
Bhattacharjee, U., & Sharma, I. (2025) · Livestock diseases and management · doi:10.1007/978-981-96-1885-9_14 · Cited by 2
Comparative study of liposomal amphotericin B, posaconazole, and micafungin for primary antifungal prophylaxis in pediatric patients with acute leukemia
Gottschlich, A. S., Ernst, J., Milde, T., & Gruhn, B. (2025) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-025-06289-5 · Cited by 2
Practical Applications of Tetraene Macrolide Antibiotic Lucensomycin as an Eco-Friendly Fungicide
Белахов, В. В. (2020) · Russian Journal of General Chemistry · doi:10.1134/s1070363220130174 · Cited by 2
Modelling and molecular docking studies of the cytoplasmic domain of Wsc-family, full-length Ras2p, and therapeutic antifungal compounds
Vélez, V., Carrasquillo-Carrión, K., Santini-González, J., Ramos-Valerio, Y. A., Vázquez-Quiñones, L. E., Roche-Lima, A., Rodríguez-Medina, J. R., & Parés-Matos, E. I. (2019) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2019.01.001 · Cited by 2
Antifungal Drugs
Bustamante, B., Hidalgo, J. A. M., & Campos, P. E. (2017) · Springer eBooks · doi:10.1007/978-3-319-64113-3_2 · Cited by 2
Cyanotic Raynaud's phenomenon induced by amphotericin B deoxycholate: A case report
Hatem, N. A., Denicol, T. L., Dagostini, C. M., & Pasqualotto, A. C. (2023) · Medical Mycology Case Reports · doi:10.1016/j.mmcr.2023.06.003 · Cited by 2
A Review of Analytical Methods for Quantification of Amphotericin-B in Marketed Dosage form and Biological Samples
Bhagyasri, C., Gollu, G., & Godela, R. (2024) · Pharmaceutical Chemistry Journal · doi:10.1007/s11094-024-03281-0 · Cited by 2
The advantages of nanomedicine in the treatment of visceral leishmaniasis: between sound arguments and wishful thinking
Matha, K., Calvignac, B., Gangneux, J., & Benoît, J. (2020) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2021.1853701 · Cited by 2
Antifungal macrocycle antibiotic amphotericin B — its present and future. Multidisciplinary perspective for the use in the medical practice
Baghirova, A. A., & Kasumov, K. M. (2021) · Biomeditsinskaya Khimiya · doi:10.18097/pbmc20216704311 · Cited by 2
Refractory keratitis from Beauveria bassiana—Successful treatment with intrastromal amphotericin B and micafungin
de la Presa, M., McCafferty, B. K., & Page, M. A. (2020) · Journal of Cataract and Refractive Surgery Online Case Reports · doi:10.1097/j.jcro.0000000000000017 · Cited by 2
Revisiting the nano option for overcoming antibiotic resistance
Schwendeman, S. P. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.11.026 · Cited by 2
Relationship between renal dysfunction and change in serum electrolyte levels in patients administered with liposomal amphotericin B
Yamashiro, K., Hirata, A., Ota, R., Ogata, F., Nakamura, T., & Kawasaki, N. (2021) · Fundamental Toxicological Sciences · doi:10.2131/fts.8.147 · Cited by 1
A Langmuir-Blodgett Study of the Interaction between Amphotericin B and Lipids of Histoplasma capsulatum
Marín, P. A., Díaz, A. N., Gómez, L. F., Jiménez, M. D. P., Castelli, F., Sarpietro, M. G., Giordani, C., & Jaramillo, C. A. P. (2022) · Membranes · doi:10.3390/membranes12050483 · Cited by 1
Development of a Bioanalytical Method for the Determination of Aureofungin and Its Sodium Salt Derivative Using HPLC: an Application to Pharmacokinetic Studies
Sankaran, S. N., Soni, R. M., More, S., Sathiyanarayanan, A., Ghaisas, M. M., Mohite, S., & Lohidasan, S. (2023) · Journal of Analytical Chemistry · doi:10.1134/s1061934823080154 · Cited by 1
Current Challenges and Nanotechnology-Based Pharmaceutical Approaches for the Treatment and Control of Visceral Leishmaniasis
Yadagiri, G., & Mudavath, S. L. (2023) · Springer eBooks · doi:10.1007/978-981-99-2302-1_20 · Cited by 1
Prophylactic use of liposomal amphotericin B in children and adolescents undergoing allogeneic hematopoietic cell transplantation: A 10-years single center experience
Rotte, L. G. Y., de Koning, C. C. H., Loeffen, Y. G. T., Bierings, M., Boelens, J. J., Lindemans, C. A., & Wolfs, T. F. W. (2024) · EJC Paediatric Oncology · doi:10.1016/j.ejcped.2024.100175 · Cited by 1
Functional Rehabilitation – an Integral Component for Quality of Life in the Holistic Management of COVID-19 Associated Mucormycosis
Pandey, A. K., Kaur, A., Gaur, S., Kohli, A., Goyal, A., Soni, K. D., Sharma, V., Jain, V., Yadav, T., Kumar, D., et al. (2024) · Indian Journal of Otolaryngology and Head & Neck Surgery · doi:10.1007/s12070-024-05037-4 · Cited by 1
Preoperative Administration of Amphotericin B in Orbital Mucormycosis Management: A Case Report
Wagner, R. T., Berardinelli, J., Fukui, M. B., Khalili, S., Mundi, N., Kassam, A. B., & Winkler, S. J. (2025) · Journal of Neurological Surgery Reports · doi:10.1055/a-2558-6468 · Cited by 1
Protein-mediated stabilization of amphotericin B increases its efficacy against diverse fungal pathogens
Fernandes, K. E., Johnston, C. L., Williams, B. C., Carter, D. A., & Sunde, M. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.00686-25 · Cited by 1
In Silico and in Vitro Evaluation of Synthetic Chalcones against Paracoccidioides brasiliensis
Pereira, G. D. C., Monteiro, J. R. B., da Costa, F. A. C., Oliveira, M., Farias, E. V., Carnielli‐Queiroz, L., Taborda, C. P., Coitinho, J. B., dos Santos, R. B., Kitagawa, R. R., et al. (2025) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c25-00044 · Cited by 1
Amphotericin B
Bubna, A. K. (2025) · Springer eBooks · doi:10.1007/978-981-95-3791-4_18 · Cited by 1
Alkylation-based optimization of antifungal FPPS inhibitors yields a potent, broad-spectrum lipophilic zoledronate derivative
Kane, A., Lai, F., Rothwell, J. G., Dinh, T. T. H., Campbell, L. T., Cain, A. K., Hibbs, D. E., Hanrahan, J. R., & Carter, D. J. (2025) · mBio · doi:10.1128/mbio.03199-25 · Cited by 1
Liposomal antimicrobials in the fight against bacterial and fungal pathogens: Clinical successes and development challenges
Kenaan, H., Duncan, R., Al-Jamal, W. T., Jones, D. S., Andrews, G. P., Gilmore, B., Yardley, V., Farrington, N., Stott, K. E., Lawrence, D. S., et al. (2025) · International Journal of Pharmaceutics X · doi:10.1016/j.ijpx.2025.100478 · Cited by 2
Self-citation
Commercial Products of Microbes: An Overview
Bagde, P. H., Deb, B., Shrivastava, H., Kandpal, M., & Jha, H. C. (2026) · Springer eBooks · doi:10.1007/978-981-95-5378-5_5 · Cited by 1
Development of a Turmeric Essential Oil-Based Nanoemulsion for Amphotericin B with Improved Solubility, Sustained Release, and Synergistic Antifungal Efficacy
Mathew, D., Thomas, B., M., S. N., Thomas, J. B., & Radhakrishnan, E. K. (2026) · BioNanoScience · doi:10.1007/s12668-026-02411-0 · Cited by 1
Lipid Nanoparticles for Drug Delivery
Zhou, Y., Jiang, R., & Chen, W. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-34203-5.00003-6 · Cited by 1
Nephrotoxicity Risk Assessment of Liposomal Amphotericin B in Hematology–Oncology Patients: A Real-World Study From Saudi Arabia
Almazmomi, M. A., Abbas, A., Alamri, A. Y., Albariqi, R. A., Motadares, M. I., AlKudiri, S., Alwadie, A. F., Alzahrani, A. M., & Alzahrani, Y. A. (2026) · International Journal of Pharmacology · doi:10.31083/ijp47889 · Cited by 1
Candidemia Attributed to a Urinary Tract Source: Retrospective Cohort Study of Risk Factors, Clinical Profiles, Therapeutic Approaches and Outcomes
Díez-Vidal, A., Hernández, A. L. D. C., Grandioso-Vas, D., Martínez-Martín, P., Marcelo, C., López, C. M. O., Grela, A. D. G., García, E. G. T., Cendejas‐Bueno, E., García‐Rodríguez, J., et al. (2026) · Mycopathologia · doi:10.1007/s11046-026-01063-8 · Cited by 1
Management of Candida Infections of the Urinary System
Stewart, A. G., & Hammond, S. P. (2026) · Current Fungal Infection Reports · doi:10.1007/s12281-026-00527-0 · Cited by 1
Efficacy of liposomal amphotericin B eye drops at two concentrations in experimental aspergillus keratomycosis in rabbits
Amalia, H., Ridwan, R., Estuningtyas, A., Sitompul, R., Adawiyah, R., & Freisleben, H. (2026) · Acta Biochimica Indonesiana · doi:10.32889/actabioina.240 · Cited by 1
Biological Safety Analysis of Nanoparticles: Exploring Toxicity, Mechanisms, and Safety Factors for Pharmaceuticals
Huang, A., Jiang, Z., Liang, Z., 汤纳平, Liu, J., Yu, X., Wang, B., & Wang, X. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s602693 · Cited by 1
Liposomal Methylglyoxal Targets Virulence and Intracellular Persistence to Overcome Amphotericin B Resistance in Cryptococcus neoformans
Khan, M. A., Khan, M. A., Azam, M., Iqubal, M. Z., & Younus, H. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27114773 · Cited by 1
From natural product to nanomedicine: Advances in smart capsaicin delivery systems for the treatment of complex diseases
Tan, J., Geng, W., Ju, T., Liu, S., Chen, Z., Li, P., Liu, K., Liu, X., Zhao, Q., Wang, K., et al. (2026) · Sustainable materials and technologies · doi:10.1016/j.susmat.2026.e02095 · Cited by 1
Phenotype-Guided Nanotherapeutic Strategies for Carbapenem-Resistant Acinetobacter baumannii: Toward Precision Antimicrobial Intervention
Elbehiry, A., Abalkhail, A., Alhumaydhi, F. A., & Marzouk, E. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18060716 · Cited by 1
WHO Critical Priority Fungi: A Comprehensive Review of Antifungal Resistance, Emerging Therapeutic Strategies, and the Potential of Antifungal Peptides
Finkina, E. I., Shevchenko, O. V., Gerasimova, А. А., Fateeva, S. I., Баландин, С. В., & Ovchinnikova, T. V. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27188141 · Cited by 1
Potential Ecotoxicological Risk of Nanopharmaceuticals in the Aquatic Environment
Bebianno, M. J., Rocha, T. L., Pontes, J. F., Amaral, A. C., & Grenha, A. (2020) · Environmental chemistry for a sustainable world · doi:10.1007/978-3-030-44921-6_8 · Cited by 1
The Safety and Effectiveness of Antifungal Medications in the Management of Mucormycosis during the COVID-19 Pandemic
Jose, D., Nair, K. S., Alagesan, M., & Pappachan, J. M. (2023) · Current Drug Safety · doi:10.2174/1574886318666230409145228 · Cited by 1
Liposomal doxorubicin and free doxorubicin in vivo quantitation method developed on CE‐LIF and its application in pharmacokinetic analysis
Tie, C., Jiang, X., Zhu, C., & Wu, C. (2023) · Electrophoresis · doi:10.1002/elps.202300076 · Cited by 1
Disseminated Histoplasmosis in Central California Seen in an Immunocompromised Patient
Ghadiya, K., Dunn, R., Singh, G., Lai, H., & Garcia-Pacheco, R. (2023) · Journal of Investigative Medicine High Impact Case Reports · doi:10.1177/23247096231205347 · Cited by 1
Anti-infective Drug Nanosystems
Ginn, C., Burton, M. J., & Mohamed-Ahmed, A. H. A. (2024) · Springer eBooks · doi:10.1007/978-3-031-59478-6_17 · Cited by 1
Molecular Effects of Zwitterionic Peptide on Monolayer Lipid Membranes upon Enzyme-Catalyzed Degradation
Feng, B., Du, S., Yang, Y., Zhu, Y., McKeague, N., Lin, B., Bu, W., Cheng, G., & Liu, Y. (2025) · Langmuir · doi:10.1021/acs.langmuir.4c04426 · Cited by 1
Liposomal amphotericin-B-induced atrial fibrillation with hypomagnesaemia in acute invasive mucormycosis of the right maxillary sinus
Nekkanti, D., Yogeesha, B. S., Manasa, R., & Darshan, M. S. (2025) · Indian Journal of Physiology and Pharmacology · doi:10.25259/ijpp_222_2024 · Cited by 1
Efficacy of liposomal amphotericin against febrile neutropenia in pediatric patients receiving prophylactic voriconazole
Kobayashi, R., Matsushima, S., Hori, D., Sano, H., Suzuki, D., Kishimoto, K., Nakano, T., Yanagi, M., Kodama, K., & Kobayashi, K. (2020) · Pediatrics International · doi:10.1111/ped.14450 · Cited by 1
Antifungal treatment administered in OPAT programs is a safe and effective option in selected patients
Gil-Navarro, M. V., Márquez, R. L., Gutiérrez, N. B., Álvarez‐Marín, R., Navarro-Amuedo, M. D., Praena‐Segovia, J., Carmona-Caballero, J. M., Fraile-Ramos, E., & López-Cortés, L. E. (2020) · Enfermedades infecciosas y microbiologia clinica (English ed ) · doi:10.1016/j.eimce.2020.01.016 · Cited by 1
Hypersensitivity Reactions to Liposomal Amphotericin in a Bone Marrow Transplant Patient
Alsajri, A. H., Al-Hishma, S. W., & Shubber, M. A. (2022) · Medical Journal of Babylon · doi:10.4103/mjbl.mjbl_67_22 · Cited by 1
Optimisation du traitement préventif et curatif de la mucormycose pulmonaire
Brunet, K. (2020) · theses.fr (ABES) · doi:10.70675/1367c1e7zd412z4f2ez9be3zb15a2d64bb30 · Cited by 1
“Inflamma” and Other “Somes”
Shader, R. I. (2018) · Clinical Therapeutics · doi:10.1016/j.clinthera.2018.12.011
Pharmacokinetics of Liposomal Amphotericin B for Injection in Chinese Healthy Subjects Based on a Bioequivalence StudyPreprint
Zhang, X., Qi, H., Wang, M., Ji, Y., Li, C., & Zhao, L. (2021) · Research Square · doi:10.21203/rs.3.rs-416411/v1
Effects of Obesity and Type 2 Diabetes on the Pharmacokinetic and Pharmacodynamic Properties of AmBisome
Slarve, I. (2021)
Effect of organic manures on residual fertility status after harvest of hybrid cotton.
Gunjal, P., Joshi, M., Bhaskar, S., & Sudhakar, K. (2009) · Mysore Journal of Agricultural Sciences
The Colt for Phoenix: Mucormycosis in COVID-19 times
Sharanabasamma, M., & M, V. B. (2022) · IP International Journal of Ocular Oncology and Oculoplasty · doi:10.18231/j.ijooo.2021.074
Amphotericin-B
Haddad, N., Bechwati, M., Ayoub, H., Zeenny, R. M., & Kanj, S. S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00140-7
Fungal Infections in the ICU
Molyneaux, I., & Bose, S. (2020) · Springer eBooks · doi:10.1007/978-981-15-4039-4_23
Atividade da paromomicina "in vitro" contra isolados clínicos de "Leishmania spp." e sua eficácia "in vivo" no tratamento da leishmaniose tegumentar
Coser, E. M. (2020) · doi:10.47749/t/unicamp.2020.1127034
Faculty Opinions recommendation of The viscoelastic properties of the fungal cell wall allow traffic of ambisome as intact liposome vesicles.
May, R. C. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.732646483.793544980
Effect of Synergism of Thalidomide and Liposomal Amphotericin-B on Leishmania tropica and Leishmania donovani Promastigote
Al-Mamary, N. I., & Al-Hayali, H. L. (2022) · Bionatura · doi:10.21931/rb/2022.07.02.59
Conclusion, Outlook, and Prospects: Bionanomaterials in Clinical Utilization
Aljabali, A. A. A., Pal, K., Bashatwah, R. M., & Tambuwala, M. M. (2022) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815051278122010010
Nanovesicles for hepatic-targeted drug delivery
Kumar, M., Jha, A., Bharti, K., & Mishra, B. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91865-7.00015-8
COVID 19 and Mucormycosis Co-infection
Nayak, N. (2021) · Nepal Journal of Medical Sciences · doi:10.3126/njms.v6i2.42229
Endovascular Infusion of Amphotericin B for the Treatment of Rhino-Orbito-Cerebral Mucormycosis: A Pilot Study Assessing Technical Feasibility and Safety
Kumar, S., Bhavana, K., Kumar, V. L., Kumar, A., & Mahto, M. (2022) · The Arab Journal of Interventional Radiology · doi:10.1055/s-0042-1757783
Foreword
Pagliuca, A., & Akova, M. (2022) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkac350
Liposomal Amphotericin-B Infusion-related Reactions and Rate of Infusions: A Single Center Cohort Study
Banakh, I., Hua, Q. A., & Metcalfe, J. (2022) · Journal of Microbiology and Infectious Diseases · doi:10.5799/jmid.1218636
Comparison of the Concentration of Amphotericin B in Periocular Fat Tissue after Retrobulbar and Intravenous InjectionPreprint
Baghaei, A., Shahriari, M., Sayyadi, S., Amiri-Andebili, M., & Esmaily, H. (2023) · Research Square · doi:10.21203/rs.3.rs-2908728/v1
Design, synthesis, and in-vitro biological evaluation of novel derivatives of amphotericin B
Gao, M., Chen, P., & Yu, Y. (2023) · Scientia Sinica Chimica · doi:10.1360/ssc-2023-0088
DEVELOPMENT OF AMPHOTERICIN-B LOADED NANOPARTICLES AND EVALUATION THE ANTIMICROBIAL POTENCY
Öz, U. C., Rızvanoğlu, S. S., Abamor, E. Ş., CENGİZ, G., Berber, H., Derman, S., Eryılmaz, M., & Bozkır, A. (2023) · Ankara Universitesi Eczacilik Fakultesi Dergisi · doi:10.33483/jfpau.1352203
Otimização de uma classe de benzenossulfonamidas como agentes anti-trypanosomatidae: planejamento, síntese e avaliação biológica contra Trypanosoma cruzi e Leishmania infantum
Hercos, G. F. D. L. (2023) · doi:10.14393/ufu.di.2023.494
Investigação da suscetibilidade à anfotericina B e à miltefosina em isolados clínicos de "Leishmania" spp
Ferreira, B. A. (2022) · doi:10.47749/t/unicamp.2022.1238138
Therapeutic Potential of Fungal Endophyte-Derived Bioactive Compound in Protozoan Diseases
Singh, V. K., Tiwari, R., Kumar, A., Rajneesh, Gupta, R. P., & Kumar, R. (2024) · Fungal biology · doi:10.1007/978-3-031-49112-2_8
Comprehensive Review on COVID-19 associated Mucormycosis: Diagnosis, Types and Treatment
Munot, N. M., Raut, M. T., Kandekar, U., Rai, N., & Gaikwad, P. V. (2024) · Biosciences Biotechnology Research Asia · doi:10.13005/bbra/3227
Therapeutic drug monitoring of selected antifungal agents
Krasowski, M. D. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18649-3.00026-4
Topical liposomal amphotericin B with surgical debridement in primary cutaneous mucormycosis
Mittal, R., Tuknayat, A., Singla, N., Bhagat, R., & Bhalla, M. (2024) · Indian Journal of Dermatology Venereology and Leprology · doi:10.25259/ijdvl_401_2024
Traditional practices in CNS drug delivery
Singh, G., Singh, A., Bhatia, R., Singh, R., Kaur, D., & Narang, R. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13474-6.00028-7
Recent Advances in the Management of Aspergillosis
Gupta, C., & Dar, S. A. (2024) · Springer eBooks · doi:10.1007/978-981-97-4909-6_16
Comparative Study of Periocular Fat Tissue Concentrations Following Retrobulbar, Intravenous, and Combined Retrobulbar-Intravenous Injection of Liposomal Amphotericin B in Rats
Shahriari, M., Baghaei, A., Soleymani, S. M., Sayadi, S., Amiri-Andebili, M., Heidarian, A., & Esmaily, H. (2024) · Journal of Kermanshah University of Medical Sciences · doi:10.5812/jkums-150405
Antifungal Agents
Lockhart, S. R., & Berkow, E. L. (2023) · ClinMicroNow · doi:10.1002/9781683674849.mcm0133
Drug Delivery in PROSE Device as Alternative to Frequent Drop Administration in Severe Ocular Surface Disease
Bian, Y., & Jacobs, D. S. (2024) · Eye & Contact Lens Science & Clinical Practice · doi:10.1097/icl.0000000000001163
Antifungal Agents
Lockhart, S. R., & Berkow, E. L. (2023) · ClinMicroNow · doi:10.1002/9781683670438.mcm0133
Antifungal Agents and Therapeutic Approaches in the Treatment of Invasive Fungal Infections
Choudhary, P., Punia, A., Kumari, S., & Chhillar, A. K. (2025) · Current Bioactive Compounds · doi:10.2174/0115734072368372250203055808
Multi-drug tolerance in Leishmania persister-like cells
Aroni-Soto, A., Monsieurs, P., Goovaerts, O., Choukri, K., Khanal, B., Adriaensen, W. J., Dujardin, J., Barrett, M. P., & Domagalska, M. A. (2026) · Communications Biology · doi:10.1038/s42003-026-10456-w
Cryptococcus albidus meningitis: A case report and literature review
Wang, G., Liu, H., Wang, X., & Li, Z. (2025) · Medicine · doi:10.1097/md.0000000000042125
Breaking barriers: Precision approaches to combat brain-eating amoebae infection
Siddiqui, R., Lloyd, D., Conway, M. E., & Khan, N. A. (2025) · Acta Tropica · doi:10.1016/j.actatropica.2025.107643
Antifungal Agents
Groll, A. H., & Walsh, T. J. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-82763-8.00256-9
Antileishmanial activity of Fenugreek, Thyme, and Rosemary essential oil nanoemulsions - a comprehensive study with mechanistic insights
Patel, J., Sharma, K., Chaudhari, R. H., Kumar, A., & Sengupta, S. (2025) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2025.128008
Thermal and Chemical Characterization of Freeze‐Thawed Poly(Vinyl Alcohol) Nanofibers Loaded With Amphotericin B for Advanced Biomaterial Applications
Vaz, M. E., & Picciani, P. H. S. (2025) · Journal of Applied Polymer Science · doi:10.1002/app.57830
Early and Stable Mouse Model of Amphotericin B‐Induced Acute Kidney Injury: Application of Continuous Non‐Invasive GFR Monitoring
Shen, L., Song, Y., Yu, X., Xin, Y., Liu, Y., Liu, Y., Luo, Y., Zhang, Q., Wang, X., Yu, K., et al. (2025) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.70071
Can liposomal amphotericin B be used as a preventive measure for cryptococcal meningitis?
Schwartz, E. L., Bahr, N. C., & Rajasingham, R. (2025) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2025.2569051
Medicinal Plant-Derived Nanoparticles Against Pathogenic Candida species
Kadir, A. K. M. S., Zerin, F. F., Tripura, S., Dutta, T., Malek, A., Rasool, A., & Batool, S. (2025) · Springer eBooks · doi:10.1007/978-3-032-03604-9_10
Cutting-edge Pharmacological Innovations for Enhanced Post-surgical Wound Healing: Integrating Nanomedicine, Targeted Drug Delivery, and Natural Therapeutics
Patil, S. K., & Asutkar, S. G. (2025) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.1177/0976500x251367992
Single high-dose liposomal amphotericin B plus B/F/TAF for AIDS-associated talaromycosis in China: a multicentre randomised controlled trial protocol
Yan, X., Meng, X., Song, W., Liu, L., Chen, J., Zhang, R., & Shen, Y. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-105648
Candidiasis infection and nanotherapeutic strategies for treatment
Mayattu, K., & Ghormade, V. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29273-6.00008-4
Diagnosis and management of invasive candidiasis in critically ill patients: SIAARTI multidisciplinary statement
Cortegiani, A., PASCALE, G. D., Angelis, G. D., Falcone, M., Ferrini, A., Forniti, A., Gatti, M., Girardis, M., Grasselli, G., Pea, F., et al. (2025) · Journal of Anesthesia Analgesia and Critical Care · doi:10.1186/s44158-025-00299-y

Authors: Stone, N. R. H., Bicanic, T., Salim, R., & Hope, W.
Affiliations: St George's, University of London (GB)
Royal Liverpool University Hospital (GB)
University of Liverpool (GB)
Corresponding author: Stone, Neil R. H.
ORCID: Stone, Neil R. H.
Bicanic, Tihana
Hope, William
Venue: Drugs
Publisher: Springer Science and Business Media LLC
Published: 2016-01-27
Volume: 76
Issue: 4
Pages: 485-500
ISSN: 0012-6667 (ISSN-L)
1179-1950
DOI: 10.1007/s40265-016-0538-7
PMC: PMC4856207
OpenAlex: W2298912458
Cited by: 537
References: 119
Citations by year: 2026: 52 · 2025: 81 · 2024: 73 · 2023: 61 · 2022: 73 · 2021: 60 · 2020: 55 · 2019: 40 · 2018: 16 · 2017: 23 · 2016: 1
FWCI: 4.10
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Drugs (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: Wellcome Trust Strategic Award (Medical Mycology and Fungal Immunology) (RG12848-10)
Topics: Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
Keywords: liposomal amphotericin B, amphotericin B deoxycholate, pharmacokinetics, pharmacodynamics, antifungal agents, opportunistic fungal infection, drug toxicity, dosing regimen, intermittent dosing, neonates, pregnancy, obesity, molecular pharmacology
MeSH terms: Amphotericin B, Animals, Chemistry, Pharmaceutical, Clinical Trials as Topic, Deoxycholic Acid, Drug Combinations, Half-Life, Humans, Tissue Distribution

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Liposomal Amphotericin B (AmBisome®): A Review of the Pharmacokinetics, Pharmacodynamics, Clinical Experience and Future Directions

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks